Our look is new. Our purpose is the same. Learn more about our brand evolution.
Our new issue of the FSHD Advocate, the first of 2021, is now available online. For those of you who receive our flagship magazine by the postal service, it will […]
[…] product pipeline is championed by the small molecule GBC0905 (Rebastinib) aimed at the treatment of FSHD Type 1 and Type 2. Myocea was spun out of San Diego-based Genea Biocells […]
Our inaugural Los Angeles Walk & Roll to Cure FSHD made the local TV news in Torrance, CA, this week! The event was organized by the Los Angeles chapter of […]
World FSHD Day was a HUGE Success! Thank you to all of you who hosted events and participated! Here are a few highlights: The Tampa Chapter and George Pollock Raced Across America with […]
[…] global platform for the discussion and dissemination of state-of-the-art research on facioscapulohumeral muscular dystrophy ( FSHD). Nearly 200 researchers, clinicians, industry representatives and patient advocates are attending. Researchers who have […]
